Targeted nanoparticle-polypeptide bioconjugates for breast cancer therapy

F. Alexis, P. Basto, E. Levy-Nissenbaum, F. Gu, A. Radovic-Moreno, R. Langer, O. C. Farokhzad

Producción científica: Capítulo del libro/informe/acta de congresoContribución a la conferenciarevisión exhaustiva

Resumen

Novel approaches that allow for a more effective and less toxic chemotherapy for disseminated breast cancer are needed for which the current therapies are largely ineffective. We report the development of controlled release polymer nanoparticles using a poly (D,L lactic)-poly(ethylene glycol) copolymer with a terminal maleimide functional group (PLA-PEG-MAL). These nanoparticles were conjugated to a polypeptide sequence that has preferential binding characteristics for the Her-2 receptor, a well characterized antigen that is over-expressed on the surface of breast cancers. The conjugation of the peptide does not affect the physical properties of the nanoparticles and we did not observe any nanoparticle aggregation. We next demonstrated a differential cytotoxity of these bioconjugates using docetaxel encapsulated targeted nanoparticles. These bioconjugates specifically bound to and were taken up by the Her2 expressing cells resulting in enhanced differential cytotoxity to empty nanoparticle controls. These targeted drug delivery nanoparticles could be used as a powerful therapeutic tool for Her2 expressing cancers.

Idioma originalInglés
Título de la publicación alojada2007 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2007, Technical Proceedings
Páginas356-358
Número de páginas3
EstadoPublicada - 2007
Publicado de forma externa
Evento2007 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2007 - Santa Clara, CA, Estados Unidos
Duración: 20 may. 200724 may. 2007

Serie de la publicación

Nombre2007 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2007, Technical Proceedings
Volumen2

Conferencia

Conferencia2007 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2007
País/TerritorioEstados Unidos
CiudadSanta Clara, CA
Período20/05/0724/05/07

Huella

Profundice en los temas de investigación de 'Targeted nanoparticle-polypeptide bioconjugates for breast cancer therapy'. En conjunto forman una huella única.

Citar esto